Serum Institute of India To Prioritize Getting Vaccines to COVAX Facility
The Serum Institute of India (SII) – the makers of the CoviShield or AstraZeneca vaccine – says it will prioritize getting vaccines to the COVAX facility, even as it faces great demand. The COVAX Facility has already notified participating economies which include Antigua and Barbuda that...